作为驱动因子和治疗标在抗雄激素前列腺癌的治疗位的基因组修饰酶
Tanaya A Purohit1,2, Kayla Bahr1, Bing Yang1
1Department of Urology, School of Medicine and Public Health, University of Wisconsin, Madison, WI, United States.
Frontiers in endocrinology
|January 28, 2026
概括
前列腺癌中抗雄激素剥夺治疗的耐药性与表观遗传变化有关. 基因组修饰酶 (HME) 驱动这种进展,这表明HME抑制剂是潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 抗雄激素剥夺疗法 (ADT) 是晚期前列腺癌的主要治疗方法.
- 大多数患者最终会患上抵抗割的前列腺癌 (CRPC),这是一个难以治疗的阶段.
- 对ADT耐药性的机制尚未完全理解,但涉及到表观遗传失调.
研究的目的:
- 审查基因组修饰酶 (HMEs) 及其相关表观遗传修饰在CRPC进展中的作用.
- 讨论HME抑制剂对前列腺癌的治疗潜力.
主要方法:
- 文献综述专注于前列腺癌中的表观遗传失调.
- 对基因素PTM和HME对CRPC的贡献进行分析.
- 评估HME抑制剂作为治疗策略.
主要成果:
- 在HME和表观遗传失调的变化显著促进前列腺癌的进展和抗抗药性.
- HME调节染色质结构和基因表达,影响雄激素耐药性.
- HME 抑制剂显示出治疗的希望,但需要特定的应用.
结论:
- 由HME引起的表观遗传失调是CRPC的一个关键驱动因素.
- 针对HME提供了一种新的治疗途径,以改善晚期前列腺癌的结果.
- 以生物标志物为指导的策略和组合疗法对于有效使用HME抑制剂至关重要.
关键词:
EZH2过度表达的情况这就是NSD2SD.抗雄激素耐药性 抗雄激素耐药性割抵抗性前列腺癌是什么表观遗传学 (染色体重塑) 的研究.基因素乙化 基因素乙化 基因素乙化基因组胺甲基化 基因组胺甲基化前列腺癌是前列腺癌.更多相关视频
06:44Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
Published on: September 8, 2017
14.0K
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.6K
相关概念视频
Histone Modification
16.1K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
16.1K
Histone Modification
4.5K
4.5K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Histone Variants at the Centromere
5.0K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
5.0K
Targeted Cancer Therapies
8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.9K
Enzymes
94.6K
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
94.6K
